✦ LIBER ✦

Simultaneous assays of cancer associated antigens in benign and malignant breast diseases

✍ Scribed by Dr. P. Franchimont; P. F. Zangerle; J. C. Hendrick; A. Reuter; C. Colin

Publisher: John Wiley and Sons
Year: 1977
Tongue: English
Weight: 453 KB
Volume: 39
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197706)39:6<2806::aid-cncr2820390668>3.0.co;2-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serial analysis of fibronectin concentra

Serial analysis of fibronectin concentration in plasma of patients with benign and malignant breast diseases

✍ Ana María Eiján; Lydia Puricelli; Elisa Bal De Kier Joffé; Daniel Entin; Daniel 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB 👁 1 views

Role of tumor-associated antigen express

Role of tumor-associated antigen expression in radioimmunoguided surgery for colorectal and breast cancer

✍ Sergio Bertoglio; Pierluigi Percivale; Federico Schenone; Alberto Peressini; Car 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 2 views

One hundred thirty-six patients with colorectal and breast cancer were enrolled in a retrospective study using radioimmunoguided surgery (RIGS) with Iodine-125 (I 125 ) radiolabeled B72.3 (Group A, 73 patients) and F023C5 (Group B, 63 patients) monoclonal antibodies (MAbs). The correlation between i

Monoclonal antibody assays for measuring

Monoclonal antibody assays for measuring ovarian tumor antigen in blood. Detection of NB/70K in patients with ovarian cancer and nongynecologic diseases

✍ Suzanne Knauf 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB

Relationship among age, prostate-specifi

Relationship among age, prostate-specific antigen, and prostate volume in men with lower urinary tract symptoms (LUTS) and in different groups of men with and without benign and malignant prostate diseases

✍ Di Silverio, Franco; Sciarra, Alessandro; D'Eramo, Giuseppe; Casale, Paolo; Lore 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 1 views

## BACKGROUND. In order to enhance prostate-specific antigen (PSA) as a predictor of prostate cancer, it is necessary to understand the characteristics of this tumor marker in a population of men without evidence of prostate cancer but who are at risk for developing the condition. METHODS. In an a

Recombinant alpha-2b-interferon enhances

Recombinant alpha-2b-interferon enhances the circulating levels of a 90-kilodalton (K) tumor-associated antigen in patients with gynecologic and breast malignancies

✍ Giovanni Scambia; Pierluigi Benedetti Panici; Stefano Iacobelli; Gabriela Baiocc 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 1 views

The circulating levels of a 90-kilodalton (K) tumor-associated antigen were measured in the blood of 43 patients with gynecologic and breast malignancies who underwent a short course of recombinant alpha-2b-interferon (rIFN a-zb) (3 million U/m2/d intramuscularly [IM] for 3 days). Of the 43 patients